Innovation meets money at Biotech Showcase™ 2012 in San Francisco, January 9–11, 2012

More than 200 innovative life science firms will present their products and strategies to top investors at Biotech Showcase™ on January 9–11, 2012, to be held at the Parc 55 Wyndham Hotel – Union Square in San Francisco. Co-produced by EBD Group and Demy-Colton Life Science Advisors, the event is expected to attract upwards of 1,300 attendees and will play host to leading investment firms such as Abingworth Management, Aescap Venture, Atlas Ventures, Bay City Capital, Index Ventures, Goldman Sachs, LifeTech Capital, Life Science Angels, Sikich Investment Banking, Pappas Ventures, Sofinnova Ventures, and Yorkville Advisors.

“Each year during the second week of January, San Francisco becomes the mecca for life science companies and investors. Biotech Showcase is the home base for the innovator class of life science companies, and the firms that aim to invest in or partner with them,” said Carola Schropp, President of EBD Group. “The event is perfectly contoured to help raise the profile of presenting companies among qualified investors, and facilitate productive networking between them.”

Now in its fourth year, Biotech Showcase has emerged as the event where professional and private investors can identify and meet with the companies driving innovation in the life science industry.

“Biotech Showcase is the new ‘H&Q,’ meaning that this is where tomorrow’s market leaders can be found. With over 200 presenting companies, top-flight investment firms and 1,300 delegates expected to attend, Biotech Showcase is the platform that will help many companies get to their next value inflection point,” added Schropp.

Biotech Showcase participants include private and public equity investors, analysts, bankers, biopharmaceutical and life science industry executives and other industry professionals. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.

For more information or to register for Biotech Showcase, go

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit

About Biotech Showcase™ 2014

Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.

The 2013 edition showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. The 2013 event featured corporate presentations by 236 public and private biotechnology and life science companies, and drew 1,600 delegates who engaged in 2,500 one-to-one meetings.

Follow Biotech Showcase 2014 on Twitter: (hashtag: #BTS14)